Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.416NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.263NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.135NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.219NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.208NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.125.1 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.78 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.159NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.43.5 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBC.1.6.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.74NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.25NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.237NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBNNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.356NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.462NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.147NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.6 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.5 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.4 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.39.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.233NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.24NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.320NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.33NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.635NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.21NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.19 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
N.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AM.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.15 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.113NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BF.5.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AP.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AK.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used